Abstract
Intra-arterial (IA) chemotherapy improves the therapeutic index of administered agents. This conference has addressed this issue in great depth, and I would like to comment only on the agents doxorubicin (ADR) and cis-diamminedichloroplatinum II (CDDP). ADR has been found to be more effective in the rabbit VX-2 tumor when given IA than IV.(1) ADR IA infusion of the dog limb results in greater normal tissue uptake of ADR than IV infusion.(2) Clinical IA infusions of ADR alone have shown promise for a number of tumors.(3,4) The long plasma half-life of ADR, however, would favor the IV use of this agent.(5)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Swistel AJ, Hancock CH, Bading JR, Leyland-Jones B, Raaf JH: Pharmacokinetics of Intra-arterial versus intravenous Adriamycin in the VX-2 tumor system. Surgical forum 34: 443–444, 1983.
Didolkar MS, Kanter PM, Baffi RR, Schwartz HS, Lopez R, Baez N: Comparison of regional versus systemic chemotherapy with Adriamycin. Ann Surg (187): 332–336, 1978.
Kraybill WG, Harrison M, Sasaki T, Fletcher WS: Regional intraarterial infusion of Adriamycin in the treatment of cancer. Surg Gynec & Obstet (144): 335–338, 1977.
Nakazono M, Iwata S: Intra-arterial infusion as a preoperative chemotherapeutic treatment for bladder tumor. American Urological Association annual meeting, San Francisco, California, May 18–22, 1980.
Benjamin R.S., Riggs C.E., Jr., Bachur N.R.: Pharmacokinetics and metabolism of Adriamycin in man. Clin Pharmacol Ther (14): 592–600, 1973.
Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, Calvo D III, Samuels M, Bonura J, Loo TL: Clinical Pharmacology of intra-arterial cis-diamminedicloroplatinum (II). Cancer Res (43): 917–920, 1983.
Carlson JA, Freedman RS, Wallace S, Chuang VP, Wharton JT, Rutledge FN: Intra-arterial cis-platinum in the management of squamous cellcarcinoma of the uterine cervix. Gynecol Oncol (12): 92–98, 1981.
Cheng E, Watson RC, Fortner J, Kemeny N, Golbey R: Regional intraarterial infusion of cisplatin in primary liver cancer: A phase II trial. Proc Am Soc Clin Oncol (1): 179, 1982.
Baker S, Wheeler R, Meduec B, Keller J, Keyes J, Ensminger W: Outpatient intra-arterial chemotherapy in head and neck cancer patients using a totally implanted infusion system. Proc Am Soc Clin Oncol (11): 195, 1982.
Horiuchi M, Inuyama Y, Kohno N: Clinical pharmacology of intraarterial and intravenous cis-diamminedichloroplatinum (II). Proc XIII International Cancer Congress 13: 60, 1982.
Ajani JA, Burgess MA: Multiple squamous cell carcinoma treated with intra-arterial cisplatin in a patient with rheumatoid arthritis. Cancer Treatment Reports (66): 1987 - 1989, 1982.
Jaffe N, Knapp J, Chuang VP, Wallace S, Ayala A, Murray J, Cangir A, Wang A, Benjamin RS: Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Cancer (51): 402–407, 1983.
Calvo DB III, Patt YZ, Wallace S, Chuang VP, Benjamin RS, Pritchard JD, Hersh EM, Bodey GP Sr, Mavligit GM: Phase I-II trial of intraarterial cis-diammine dichloroplatinum (II) for regionally confined malignancy. Cancer (45): 1278–1283, 1980.
Stewart DJ, Wallace S, Feun L, Leavens M, Young SE, Handel S, Mavligit G, Benjamin RS: A Phase I study of intracarotid artery infusion of cis-diammine dichloroplatinum (II) in patients with recurrent malignant intracerebral tumors. Cancer Research (42): 2059–2062, 1982.
Pritchard JD, Mavligit GM, Benjamin RS, Patt YZ, Calvo DB, Hall SW, Bodby GP, Wallace S: Regression of regionally confined melanoma with intra-arterial cis-dichlorodiammine platinum (II). Cancer Treatment Rep 63.
Wallace S, Chuang VP, Samuels M, Johnson D: Transcatheter Intraarterial infusion of chemotherapy in advanced bladder cancer. Cancer (49): 640–645, 1982.
Dewey WC, Saparetto SA, Betten DA: Hyperthermic radiosensitization of synchronous Chinese hamster cells and relation between lethality and chromosomal aberrations. Radiation Res (76): 48 - 59, 1978.
Gerner EW: Thermotolerance in hyperthermia in cancer therapy. In Storm FK (ed) GK Hall, Boston, 1983, PP 141–162.
Song CW: Blood flow in tumors and normal tissues in hyperthermia in cancer therapy. In: Storm FK (ed) GK Hall, Boston, 1983, pp 187–206.
Herman TS, Baustian AM, Kundrat MA: Enhancement of hyperthermia induced lethality and modulation of Adriamycin cytotoxicity by cooling. Proc Am Assoc Can Res (22): 221, 1981.
Vig BK: Effect of hypothermia and hyperthermia on the induction of chromosome aberrations by Adriamycin in human leukocytes. Cancer Res (38): 550–555, 1978.
Hahn GM, Braun J, Har-Kedar I: Thermochemotherapy: Synergism between hyperthermia (42-43° C) and adriamycin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA (72): 937: 940, 1975.
Marmor JB: Interactions of hyperthermia and chemotherapy in animals. Cancer Res (39): 2269–2276, 1979.
Hahn GM: Potential for therapy of drugs and hyperthermia. Cancer Res (39): 2264–2268, 1979.
Meyn RE, Corry PM, Fletcher SE, Demetriades M: Thermal enhancement of DNA damage for mammalian cells treated with cis-diamminedichloroplatinum (II). Cancer Res (40): 1136–1139, 1980.
Fisher GA, Hahn GM: Enhancement of cis-platinum (II) diamminedichloride cytotoxicity by hyperthermia. Natl Cancer Inst Monogram (61): 255–257, 1982.
Brouwer J, Fichtinger-Schepman AM J, Van de Putte P, and Reedijk J: Influence of temperature on platinum binding to DNA, cell killing, and mutation induction in escherichia coli K-12 cells treated with cisdiamminedichloroplatinum (II). Cancer Res (42): 2416–2419, 1982.
Alberts DS, Peng YM, Chen HSG, Moon TE, Cetas TL, and Hoeschele JD: Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J.N.C. I. (65): 455–46l, 1980.
Quebbman EJ, Skibba JL, Petroff RJ Jr: A technique for isolated hyperthermic liver perfusion. J Surg Oncol (in press).
Cavaliere R, Mondovi B, Moricca G, Monticelli G, Natali PG, Santori FS, DiFillippo F, Varenese A, Aloe L, Rossi-fanelli A: Regional perfusion hyperthermia. In: Storm FK (ed) Hyperthermia in cancer therapy. GK Hall, Boston, 1983, PP 369–399.
Hild P, Aigner K, Henneking K: Levels of cis-platinum in hyperthermic isolated perfusion. Anticancer Res (2): 225–256, 1982.
Hall RR, Schade R0K, Swinney J: Effects of hyperthermia on bladder cancer. Br J Urol (2): 593–594, 1974.
England HR, Anderson JD, Minasian H, Marshall VR, Molland EA, Blandy JP: The therapeutic application of hyperthermia in the bladder. Br J Urol (47): 849–851, 1975.
Rege VB, Leone LA, Soderberg CH Jr, Coleman GV, Robidoux HJ, Fijman R, Brown J: Hyperthermic adjuvant perfusion chemotherapy for stage I malignant melanoma of the extremity with literature review. Cancer (52): 2033–2039, 1983.
Wile A, Juler GL, Rosenberg H, Haiouc Nf Stemmer EA: Control of pelvic cancer with hyperthermic isolation-perfusion. J Surg Res (34): 560–567, 1983.
Hall RR, Wadehra V, Towler JR, Hindmarsh JR, Byrne PO: Hyperthermia in the treatment of bladder tumours. Br J Urol (48): 603–608, 1976.
Shingelton WW, Parker RT, Mahaley S: Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery (50): 260–265, 1961.
Spratt JS, Adcock RA, Sherrill W, Travathon S: Hyperthermic peritoneal perfusion system in canines. Cancer Res (40): 253–255, 1980.
Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J: Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res (40): 256: 260, 1980.
Shiu MH, Fortner JG: Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res (40): 4081–4084, 1980.
Hume SP, Marigold JCL, Michalowski A: The effect of local hyperthermia on nonproliferative, compared with proliferative, epithelial cells of mouse intestinal mucosa. Radiat Res (94)252–262, 1983.
Jain RK: Bioheat transfer: Mathematical models of thermal systems. In: Storm FK (ed) Hyperthermia in cancer therapy. GK Hall, Boston, 1983, pp 9–46.
Christensen DA: Thermometry and thermography. In: Storm FK (ed). Hyperthermia in cancer therapy. GK Hall, Boston, 1983, pp 223–232.
Jacobs SC, Lawson RK: Pathologic effects of pre-cystectomy therapy with combination intra-arterial doxorubicin hydrochloride and local bladder hyperthermia for bladder cancer. J Urol (127): 43–47, 1982.
Meshorer A, Prionas SD, Fajardo, LF, Meyer JL, Hahn GM, Martinez AA: The effects of hyperthermia on normal mesenchymal tissues. Arch Pathol Lab Med (107)328–334, 1983.
Bonnem EM, Litterst CL, Smith FP: Platinum concentrations in human glioblastoma multiforme following the use of cisplatin. Cancer Treat Rep (66): 1661–1663, 1983.
Litterst CL, LeRoy AF, Guarrino AM: Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammine platinum (II) to animals. Cancer Treat Rep (63): 1485–1492, 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Jacobs, S.C. (1984). Intracavitary Hyperthermia and Intra-arterial Chemotherapy. In: Howell, S.B. (eds) Intra-Arterial and Intracavitary Cancer Chemotherapy. Developments in Oncology, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3843-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3843-7_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3845-1
Online ISBN: 978-1-4613-3843-7
eBook Packages: Springer Book Archive